2023 annual financial data

Eton Pharmaceuticals 2023 Financial results

Direct answer

Revenue was 31.64M USD.

Operating income was -1.19M USD and net income was -936,000 USD.
Operating cash flow was 6.82M USD.

Get free Eton Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
31.64M USD
Operating income
-1.19M USD
Net income
-936,000 USD
Operating cash flow
6.82M USD